对出血时间的批判性重新评估
R P Channing Rodgers1,2, Jack Levin1,2
1Department of Laboratory Medicine, School of Medicine, University of California, San Francisco, California.
Seminars in thrombosis and hemostasis
|December 12, 2023
概括
出血时间测试是评估出血障碍的历史方法,涉及到皮肤切口的时间. 本次审查重新评估了其诊断实用性和历史修改.
科学领域:
- 血液学 血液学 血液学
- 临床病理学 临床病理学
背景情况:
- 流血时间测试,首次描述于1901年,是评估血液静止的一个历史性的方法.
- 许多修改,包括广泛使用的常春藤出血时间,已经开发出标准化程序.
- 该测试已被提出用于诊断血小板疾病,监测治疗,并预测出血风险.
研究的目的:
- 为了提供对出血时间测试的全面审查.
- 分析出血时间测试的历史发展和应用.
主要方法:
- 1990年进行了一项文献搜索,发现了讨论出血时间的862份文件.
- 该审查侧重于出血时间测试的演变和修改.
主要成果:
- 血液流血时间测试已被提出用于诊断血小板疾病,评估治疗疗效,并预测出血.
- 常见的方法是Ivy方法,涉及前臂切口和控制的静脉压力,是一种常见的变体.
结论:
- 从历史上看,出血时间测试在评估血液静止和血小板功能方面具有重要意义.
- 尽管有局限性,但该测试已被用于血液疾病的诊断和预后目的.
- 这次复刊提供了对基本血静评估工具的历史视角.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708


